Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment

Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment

Neuroprotective drugs to protect the brain against cerebral ischemia and reperfusion (I/R) injury are urgently needed. Mammalian cell-produced recombinant human erythropoietin (rhuEPO<sup>M</sup>) has been demonstrated to have excellent neuroprotective functions in preclinical studies, b...

Full description

Bibliographic Details
Main Authors:	Farooqahmed S. Kittur, Chiu-Yueh Hung, P. Andy Li, David C. Sane, Jiahua Xie
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Pharmaceuticals
Subjects:	multimodal neuroprotectant erythropoietin hematopoietic activity asialo-erythropoietin non-erythropoiesis erythropoietin receptor
Online Access:	https://www.mdpi.com/1424-8247/16/4/610

Similar Items

Renal Cell Protection of Erythropoietin beyond Correcting The Anemia in Chronic Kidney Disease Patients
by: Hamid Nasri
Published: (2013-01-01)

THE STUDY OF RENOPROTECTIVE PROPERTIES OF ERYTROPOETIN DERIVATIVES ON THE KIDNEY ISCHEMIA-REPERFUSION MODEL
by: V. V. Elagin, et al.
Published: (2018-12-01)

Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor
by: Carolina Castillo Hernández, et al.
Published: (2017-01-01)

Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection
by: Bongki Cho, et al.
Published: (2022-02-01)

How to select appropriate hemoglobin target levels on health-related quality of life and outcomes for patients with chronic kidney disease?
by: Filippo Salvati
Published: (2013-12-01)

Erythropoietin Receptor (EpoR) Agonism Is Used to Treat a Wide Range of Disease
by: Fabian Sanchis-Gomar, et al.
Published: (2013-04-01)

Erythropoietin between therapy and doping : Two sides of the same coin
by: Ostojić Ana, et al.
Published: (2016-01-01)

Erythropoietin as a possible neuroprotective agent in patients with schizophrenia
by: George E. Barreto
Published: (2015-02-01)

Local YB-1, Epo, and EpoR concentrations in fractured bones: results from a porcine model of multiple trauma
by: Felix Marius Bläsius, et al.
Published: (2023-01-01)

The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor
by: Debbra Y. Knorr, et al.
Published: (2023-04-01)

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
by: Zamzam Awida, et al.
Published: (2022-10-01)

APPLICATION OF ERYTHROPOIETIN THETA IN THERAPY OF ANEMIA IN ONCOLOGIC PATIENTS
by: O. A. GLADKOV, et al.
Published: (2016-12-01)

Human iPSC-derived neural crest stem cells can produce EPO and induce erythropoiesis in anemic mice
by: Valerio Brizi, et al.
Published: (2021-08-01)

Erythropoietin resistance in patients with regular hemodialysis in Sohag university hospital
by: Nagwa S. Ahmed, et al.
Published: (2023-06-01)

Neuroprotective effects of erythropoietin in acute ischemic stroke
by: Bahador Asadi, et al.
Published: (2013-01-01)

A comparative pharmacokinetic and pharmacodynamic study of two novel Cuban PEGylated rHuEPO versus MIRCERA® and ior®EPOCIM
by: Gledys Reynaldo, et al.
Published: (2018-05-01)

Effect of recombinant human erythropoietin and its combination with tamoxifen on viability of MCF-7 cell in three-dimensional culture
by: Shujaaedin, Hareth Yahya Ahmed
Published: (2019)

STAT5 as a Key Protein of Erythropoietin Signalization
by: Zuzana Tóthová, et al.
Published: (2021-07-01)

Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration
by: Guan Wang, et al.
Published: (2017-11-01)

The detection of trans gene fragments of hEPO in gene doping model mice by Taqman qPCR assay
by: Kai Aoki, et al.
Published: (2020-02-01)

Enhancing Erythropoiesis by a Phytoestrogen Diarylheptanoid from <i>Curcuma comosa</i>
by: Kanit Bhukhai, et al.
Published: (2022-06-01)

Targeting Stress Erythropoiesis Pathways in Cancer
by: Sanja Vignjević Petrinović, et al.
Published: (2022-05-01)

The Neural Crest as the First Production Site of the Erythroid Growth Factor Erythropoietin
by: Ikuo Hirano, et al.
Published: (2019-06-01)

Hemoglobin During and Following a 4-Week Commercial Saturation Dive to 200 m
by: Damian Łuczyński, et al.
Published: (2019-12-01)

Erythropoietin production by the kidney and the liver in response to severe hypoxia evaluated by Western blotting with deglycosylation
by: Yukiko Yasuoka, et al.
Published: (2020-06-01)

Upregulation of erythropoietin and erythropoietin receptor in castration-resistant progression of prostate cancer
by: Chen Ye, et al.
Published: (2020-01-01)

Erythropoietin Promotes Infection Resolution and Lowers Antibiotic Requirements in E. coli- and S. aureus-Initiated Infections
by: Feihong Liang, et al.
Published: (2021-04-01)

The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p
by: Zhimin Chen, et al.
Published: (2018-07-01)

Prolonged astrocyte-derived erythropoietin expression attenuates neuronal damage under hypothermic conditions
by: Kohki Toriuchi, et al.
Published: (2020-05-01)

Endogenous neuroprotection during focal brain ischemia in rats: erythropoietin, ischemic pre- and postconditioning
by: A. A. Shmonin, et al.
Published: (2017-02-01)

SEARCH OF NEW PHARMACEUTICALS ON THE BASIS OF DARBEPOETIN IN THE TREATMENT OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
by: Konstantin Reznikov, et al.
Published: (2017-03-01)

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
by: Thea Kristin Våtsveen, et al.
Published: (2016-08-01)

Regulation of erythropoiesis: emerging concepts and therapeutic implications
by: Pu Tang, et al.
Published: (2023-12-01)

EFFECT OF METHODS OF IMMOBILIZATION OF ERYTHROPOIETIN ON THE SENSITIVITY FOR THE DETECTION OF SPECIFIC IgG TO EPO IN EXPERIMENTAL ANIMALS SERA
by: A. M. Kudryashova, et al.
Published: (2017-12-01)

"EFFECT OF HIGH VERSUS LOW DOSES OF HUMAN RECOMBINANT ERYTHROPOIETIN ON THE ANEMIA OF PREMATURITY"
by: A. Mohammadzadeh, et al.
Published: (2005-04-01)

Erythropoietin use and abuse
by: M Joseph John, et al.
Published: (2012-01-01)

Expression of erythropoietin and its receptor increases in colonic neoplastic progression: The role of hypoxia in tumorigenesis
by: Zoltan Gombos, et al.
Published: (2011-01-01)

Erythropoietin promoted the proliferation of hepatocellular carcinoma through hypoxia induced translocation of its specific receptor
by: Shuo Miao, et al.
Published: (2017-12-01)

Synthesis and biological evaluation of 125I-erythropoietin as a potential radiopharmaceutical agent for tumours
by: Gonçalo dos Santos Clemente, et al.
Published: (2011-03-01)

Effects of green tea extract treatment on erythropoiesis and iron parameters in iron-overloaded β-thalassemic mice
by: Kornvipa Settakorn, et al.
Published: (2022-12-01)